💉What Is Insulin?

The Basics: What Is Insulin?

Insulin is a peptide hormone produced by the beta cells of the pancreatic islets of Langerhans. Its primary role is to regulate blood glucose (blood sugar) levels by enabling cells throughout the body — particularly in muscle, fat, and the liver — to take up glucose from the bloodstream and use it for energy.

Think of insulin as a key. Glucose circulates in your blood, but it cannot enter your cells without a "key" to unlock the cell's receptor. Insulin is that key. Without sufficient functional insulin, glucose builds up in the bloodstream while your cells are starved of energy — the hallmark of diabetes mellitus.

How the Pancreas Produces Insulin

Under normal physiology, the pancreas monitors blood glucose levels continuously. When you eat carbohydrates, your digestive system breaks them down into glucose, which is then absorbed into the bloodstream. Rising blood glucose triggers the beta cells to secrete insulin in a two-phase response:

1. First-phase release (0–10 min): A rapid burst of pre-formed insulin stored in granules within beta cells. This blunts the initial glucose spike from a meal.
2. Second-phase release (10–60+ min): Sustained insulin secretion driven by ongoing glucose stimulation. This covers the prolonged rise in blood sugar after a meal.

Between meals and overnight, the pancreas secretes a low, steady "basal" level of insulin to suppress liver glucose production (hepatic glucose output) and keep fasting blood sugar stable — typically between 70–100 mg/dL (3.9–5.6 mmol/L).

What Does Insulin Do in the Body?

Insulin has widespread anabolic (building) effects across multiple organ systems:

• Muscle cells: Insulin triggers GLUT4 transporters to move to the cell surface, allowing glucose to enter and be used for energy or stored as glycogen.
• Fat (adipose) tissue: Insulin promotes glucose uptake and fat storage (lipogenesis) while suppressing fat breakdown (lipolysis).
• Liver: Insulin suppresses hepatic glucose production (gluconeogenesis and glycogenolysis) and promotes glycogen synthesis.
• Brain: Although the brain doesn't require insulin for glucose uptake, insulin plays important roles in appetite regulation and cognitive function.

Type 1 Diabetes: Absolute Insulin Deficiency

In Type 1 diabetes (T1D), the immune system mistakenly destroys the beta cells of the pancreas through an autoimmune process. Once enough beta cells are destroyed — typically 80–90% — the pancreas can no longer produce insulin at all. This is called absolute insulin deficiency.

Without injected insulin, people with T1D will develop diabetic ketoacidosis (DKA) — a life-threatening condition where the body burns fat at an uncontrolled rate, producing acidic ketone bodies that accumulate in the blood. T1D requires lifelong, continuous insulin therapy, typically with both a basal (long-acting) and bolus (rapid-acting) insulin.

Type 2 Diabetes: Relative Insulin Deficiency + Resistance

Type 2 diabetes (T2D) is more complex. It involves two defects working together:

1. Insulin resistance: The body's cells (especially muscle and liver) don't respond efficiently to insulin, requiring progressively higher amounts to achieve the same blood glucose effect.
2. Progressive beta cell dysfunction: Over time, the pancreas can't keep up with the increased insulin demand, and insulin secretion declines.

Many people with T2D are initially managed with oral medications (metformin, GLP-1 agonists, SGLT-2 inhibitors) and lifestyle changes. However, as the disease progresses and beta cell function declines, insulin therapy often becomes necessary — either as a supplement to oral agents or as the primary therapy.

Why Synthetic Insulin Is Needed

Since the discovery of insulin in 1921 by Banting and Best, insulin has been produced externally for therapeutic use. Early insulins were extracted from animal pancreases (bovine and porcine). Today, virtually all therapeutic insulin is produced through recombinant DNA technology — human insulin genes are inserted into bacteria or yeast, which then manufacture large quantities of human insulin.

Modern insulin analogs go a step further — scientists have modified the amino acid sequence of human insulin to create molecules with tailored pharmacokinetic profiles (different speeds of onset, peak, and duration). This allows for once-daily basal insulins (like insulin glargine) and ultra-rapid mealtime insulins (like insulin lispro-aabc).

Normal vs. Diabetic Blood Glucose Targets